USEUROPEAFRICAASIA 中文双语Français
Business
Home / Business / Technology

Cross-border healthcare platform signs deal with US medical firm

By Jing Shuiyu | chinadaily.com.cn | Updated: 2016-12-19 16:58

China's first online cross-border healthcare consulting platform Cycares signed a partnership contract with Cambridge Health Alliance, the US healthcare provider, on Monday.

Under the deal, the two sides will share their healthcare resources. Cycares CEO Joyce Xiong said this would be the first time that US general medical practitioners were introduced to Chinese clinics.

Xiong said: "Cycares aims to make foreign healthcare services available for Chinese. The partnership with CHA will enable us to offer more high-quality medical resources in the US to our clients."

Kristen K. Meisinger, medical staff president at CHA, said: "We're excited by the beginning of the partnership with Cycares across international borders, to bring our high-quality care and innovation system to China and learn from China as well."

One-year-old Cycares provides online services to help Chinese patients get second opinions from overseas hospitals. According to Xiong, it also has referred more than 100 Chinese for medical treatment in the US, Japan, South Korea, Thailand, or Singapore in the past year.

CHA is a local provider that offers bouquet of services ranging from primary care, specialized care to aged care.

It promotes the model of patient-centered and community-inspired care at the national level in the US, and also in many other countries, such as Australia, Brazil, Meisinger said.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US